Shigo, Japan

Masanao Shimano



Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kyoto, JP (1993 - 2009)
  • Shigo, JP (2014)

Company Filing History:


Years Active: 1993-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Masanao Shimano: Pioneering Medical Chemistry

Introduction: Masanao Shimano is a prominent inventor based in Shigo, Japan, known for his significant contributions to the field of medical chemistry. With a total of three patented inventions, Shimano's work focuses on innovative compounds with therapeutic potential, particularly in modulating enzyme activity.

Latest Patents: One of Masanao Shimano's notable recent patents includes the N-hydroxyformamide derivative and medicament containing the same. This compound, represented by a specific general formula, exhibits ADAM17 inhibitory activity, contributing to important advancements in medicinal chemistry. Additionally, he has developed reverse hydroxamic acid derivatives which are defined by a unique structural formula. These derivatives have shown TNF-α converting enzyme (TACE) inhibitory activity, highlighting their potential utility in treating various medical conditions.

Career Highlights: Masanao Shimano currently works at Kaken Pharmaceutical Company, Ltd., where he applies his expertise in the development of pharmaceuticals. His innovative approach and focus on medical chemistry enable him to create compounds that can lead to improved therapeutic outcomes.

Collaborations: Throughout his career, Shimano has collaborated with fellow researchers and colleagues, including Makoto Haino and Noriyuki Kamei. These collaborations have played a crucial role in enhancing the innovation and efficiency of his research projects.

Conclusion: Masanao Shimano is a dedicated inventor whose work reflects the forefront of medical chemistry. With a strong patent portfolio and enriching collaborations, his contributions are making significant strides in the field, paving the way for novel therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…